- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05584410
Digitalization of Osteoarthritis Care
Digitalization of the Care for Patients With Hip and Knee Osteoarthritis
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Susanne Beischer, PhD
- Phone Number: +46709941983
- Email: susanne.beischer@gu.se
Study Contact Backup
- Name: Maziar Mohaddes, Assoc Prof
- Phone Number: +46 (730) 701147
- Email: maziar.mohaddes_ardebili@vgregion.se
Study Locations
-
-
Västra Götaland
-
Gothenburg, Västra Götaland, Sweden
- Recruiting
- Sahlgrenska University Hospital
-
Contact:
- Susanne Beischer, PhD
- Email: susanne.beischer@gu.se
-
Contact:
- Maziar Mohaddes, PhD, Dr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
The participant:
- has given their written consent to participate in the study
- has been referred to the orthopaedic clinic at Sahlgrenska University Hospital /Mölndal for primary hip- and or knee osteoarthritis
- has a positive attitude in using digital tools
- has access to a smart phone / tablet
- has been assessed not to be in need of hip or knee surgery
Exclusion Criteria:
Patients:
- with secondary osteoarthritis (due to osteonecrosis)
- referred to a specific orthopaedic surgeon
- with impaired mental ability, reluctance or language difficulties that make it difficult to understand the meaning of participating in the study
- who undergo treatment, have disability or illness that according to the research group can affect the treatment or the study result
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: App-based model of care
The app-based model of care includes at least one physical visit at the clinic. The majority of the treatment is provided by the app, containing five different sections: 1) My information: specific information regarding osteoarthritis and generic lifestyle advice. 2 & 3) My exercise & My plan: individualized exercises where instructions are given through real-time video or pictures and written descriptions. The patient has access to a calendar and an overview of scheduled rehabilitation/exercises and care meetings. 4) My progress: weekly assessment of pain + every six-month with valid patient reported outcome measures and test of function. 5) My messages (asynchronous chat with the responsible physiotherapist). The app sends automatic and daily reminders and / or motivational notifications. |
Patient education according to national guidelines, with information about e.g.
disease progression, symptoms, treatment, exercise, self-care techniques and dietary information
Patients will be followed by validated questionnaires and function tests (30 sec Chair-to-stand test) every six months until three years after the start of treatment.
The patients will get a report of the results and a research coordinator will contact the patients if their symptoms/function has worsen and discuss further treatment
Automatic and daily reminders and / or motivational notifications
Individually based exercise programs individualized exercises where instructions are given through real-time video or pictures in combination with written descriptions.
|
Active Comparator: Web-based model of care
The patient will get access to information about osteoarthritis and generic osteoarthritis exercises program from a web-based platform Individualization of the training can be done by the responsible physiotherapist informing about changes in the training via the message function and / or during physical follow-up visits.
An individualized rehabilitation program can be given to the patient, via the platform or at a physical visit at the clinic, in form of a document with pictures and descriptive information.
As long as the patient is under treatment (approximately three months), he/she can contact their responsible physiotherapist by sending a message from the platform.
|
Patient education according to national guidelines, with information about e.g.
disease progression, symptoms, treatment, exercise, self-care techniques and dietary information
Individualized exercises that the patient performs on their own, i.e. at home or at a gym.
Generic osteoarthritis exercise, including about 20 different exercises, provided by real-time videos and written description
|
Active Comparator: Standard care
Patients who are randomized to standard care receive osteoarthritis specific information at three different group meetings (physical or digital) led by a physiotherapist, an occupational therapist and / or dietitian (each rehab clinic makes its own arrangement).
After the theory sessions, the patient is booked for another physical visit to the responsible physiotherapist where an individual training program is tested.
The patient is then offered to regularly exercise at the clinic, individually or in a group under supervision from a physiotherapist.
|
Patient education according to national guidelines, with information about e.g.
disease progression, symptoms, treatment, exercise, self-care techniques and dietary information
Individualized exercises that the patient performs on their own, i.e. at home or at a gym.
The patient is offered to regularly exercise at the clinic, individually or in a group under supervision from a physiotherapist.
Osteoarthritis specific information at three different group meeting (physical or digital) led by a physiotherapist, an occupational therapist and / or dietitian (each rehab clinic makes its own arrangement).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip dysfunction/Knee Osteoarthritis Outcome Score (HOOS/KOOS) subscale Function in daily living (ADL)
Time Frame: baseline to 12 months after inclusion
|
The KOOS/HOOS questionnaires were developed as instruments to assess the patient's opinion about their knee and associated problems.
KOOS consists of 5 subscales: Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL).
The previous week is the time period considered when answering the questions.
Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale (scoring instructions are available in a separate document).
|
baseline to 12 months after inclusion
|
Hip dysfunction/Knee Osteoarthritis Outcome Score (HOOS/KOOS) subscale Function in daily living (ADL)
Time Frame: baseline to 36 months after inclusion
|
The KOOS/HOOS questionnaires were developed as instruments to assess the patient's opinion about their knee and associated problems.
KOOS consists of 5 subscales: Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL).
The previous week is the time period considered when answering the questions.
Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale (scoring instructions are available in a separate document).
|
baseline to 36 months after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip dysfunction/Knee Osteoarthritis Outcome Score (HOOS/KOOS) subscale pain, symptoms, function in sport and recreation, and knee/hip related quality of life
Time Frame: baseline
|
The KOOS/HOOS questionnaires were developed as instruments to assess the patient's opinion about their knee and associated problems.
KOOS consists of 5 subscales: Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL).
The previous week is the time period considered when answering the questions.
Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale (scoring instructions are available in a separate document).
|
baseline
|
Hip dysfunction/Knee Osteoarthritis Outcome Score (HOOS/KOOS) subscale pain, symptoms, function in sport and recreation, and knee/hip related quality of life
Time Frame: 3 months after inclusion
|
The KOOS/HOOS questionnaires were developed as instruments to assess the patient's opinion about their knee and associated problems.
KOOS consists of 5 subscales: Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL).
The previous week is the time period considered when answering the questions.
Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale (scoring instructions are available in a separate document)
|
3 months after inclusion
|
Hip dysfunction/Knee Osteoarthritis Outcome Score (HOOS/KOOS) subscale pain, symptoms, function in sport and recreation, and knee/hip related quality of life
Time Frame: 12 months after inclusion
|
The KOOS/HOOS questionnaires were developed as instruments to assess the patient's opinion about their knee and associated problems.
KOOS consists of 5 subscales: Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL).
The previous week is the time period considered when answering the questions.
Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale (scoring instructions are available in a separate document).
|
12 months after inclusion
|
Hip dysfunction/Knee Osteoarthritis Outcome Score (HOOS/KOOS) subscale pain, symptoms, function in sport and recreation, and knee/hip related quality of life
Time Frame: 36 months after inclusion
|
The KOOS/HOOS questionnaires were developed as instruments to assess the patient's opinion about their knee and associated problems.
KOOS consists of 5 subscales: Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL).
The previous week is the time period considered when answering the questions.
Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale (scoring instructions are available in a separate document).
|
36 months after inclusion
|
The Forgotten joint score (hip/knee) (FJS)
Time Frame: baseline
|
A questionnaire that was developed to find subtle differences between patients who grade their hip / knee as "very good" and "excellent".
The score is graded from 0 to 100, where a higher score is better.
|
baseline
|
The Forgotten joint score (hip/knee) (FJS)
Time Frame: 3 months after inclusion
|
A questionnaire that was developed to find subtle differences between patients who grade their hip / knee as "very good" and "excellent".
The score is graded from 0 to 100, where a higher score is better.
|
3 months after inclusion
|
The Forgotten joint score (hip/knee) (FJS)
Time Frame: 12 months after inclusion
|
A questionnaire that was developed to find subtle differences between patients who grade their hip / knee as "very good" and "excellent".
The score is graded from 0 to 100, where a higher score is better.
|
12 months after inclusion
|
The Forgotten joint score (hip/knee) (FJS)
Time Frame: 36 months after inclusion
|
A questionnaire that was developed to find subtle differences between patients who grade their hip / knee as "very good" and "excellent".
The score is graded from 0 to 100, where a higher score is better.
|
36 months after inclusion
|
Heath-related quality of life - EuroQol (EQ5-D)
Time Frame: baseline
|
Measure of health-related quality of life and consists of 5 items.
General health is measured using a visual analog scale (0 to 100) with 100 being the best possible health state.
|
baseline
|
Heath-related quality of life - EuroQol (EQ5-D)
Time Frame: 3 months after inclusion
|
Measure of health-related quality of life and consists of 5 items.
General health is measured using a visual analog scale (0 to 100) with 100 being the best possible health state.
|
3 months after inclusion
|
Heath-related quality of life - EuroQol (EQ5-D)
Time Frame: 12 months after inclusion
|
Measure of health-related quality of life and consists of 5 items.
General health is measured using a visual analog scale (0 to 100) with 100 being the best possible health state.
|
12 months after inclusion
|
Heath-related quality of life - EuroQol (EQ5-D)
Time Frame: 36 months after inclusion
|
Measure of health-related quality of life and consists of 5 items.
General health is measured using a visual analog scale (0 to 100) with 100 being the best possible health state.
|
36 months after inclusion
|
Medtech20
Time Frame: 3 months after inclusion
|
A standardized tool measuring how medical devices affect people's sense of security, integrity, social participation and convenience.
Each item is rated on a seven graded Likert-scale from, 0 = "disagree" to 6 = "completely agree".
Each item also has a "Not applicable" response option.
A higher score indicates a better effect of the medical device.
|
3 months after inclusion
|
Working Alliance Inventory-Short Revised
Time Frame: 3 months after inclusion
|
A recently refined measure of the therapeutic alliance that assesses three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy and (c) development of an affective bond.
The questionnaire is validated, has acceptable reliability and includes 12 items.
The patient rates each item on a seven graded Likert-scale from 1 = "not at all" to 7 = "completely".
A higher score indicates a better therapeutic alliance.
|
3 months after inclusion
|
Cost Effectiveness
Time Frame: 3 months after inclusion
|
Indirect and direct health care costs.
Total costs, costs per patient and per visit.
Loss of income will be reported as number of days of abscence due to illness.
|
3 months after inclusion
|
Cost Effectiveness
Time Frame: 12 months after inclusion
|
Indirect and direct health care costs.
Total costs, costs per patient and per visit.
Loss of income will be reported as number of days of abscence due to illness.
|
12 months after inclusion
|
Cost Effectiveness
Time Frame: 36 months after inclusion
|
Indirect and direct health care costs.
Total costs, costs per patient and per visit.
Loss of income will be reported as number of days of abscence due to illness.
|
36 months after inclusion
|
Swedish National Board of Health and Welfare questions about physical activity
Time Frame: baseline
|
Questions intended for use in clinical health care to identify people that are insufficiently physically active.
The respondents report their total time, in minutes, of moderate and vigorous physical activity, respectively, during a normal week on a categorical scale from a) 0-30 minutes, up to g) >300 minutes.
|
baseline
|
Swedish National Board of Health and Welfare questions about physical activity
Time Frame: 3 months after inclusion
|
Questions intended for use in clinical health care to identify people that are insufficiently physically active.
The respondents report their total time, in minutes, of moderate and vigorous physical activity, respectively, during a normal week on a categorical scale from a) 0-30 minutes, up to g) >300 minutes.
|
3 months after inclusion
|
Swedish National Board of Health and Welfare questions about physical activity
Time Frame: 12 months after inclusion
|
Questions intended for use in clinical health care to identify people that are insufficiently physically active.
The respondents report their total time, in minutes, of moderate and vigorous physical activity, respectively, during a normal week on a categorical scale from a) 0-30 minutes, up to g) >300 minutes.
|
12 months after inclusion
|
Swedish National Board of Health and Welfare questions about physical activity
Time Frame: 36 months after inclusion
|
Questions intended for use in clinical health care to identify people that are insufficiently physically active.
The respondents report their total time, in minutes, of moderate and vigorous physical activity, respectively, during a normal week on a categorical scale from a) 0-30 minutes, up to g) >300 minutes.
|
36 months after inclusion
|
Pain Self-Efficacy Scale - 2 item
Time Frame: baseline
|
The Pain Self-Efficacy Questionnaire (PSEQ) is an established 10-item measure of pain self-efficacy that is widely used in clinical and research settings.
In the present study a short form of the original questionnaire will be used.
The two items are graded from 0 = not at all certain to 6 = very certain.
|
baseline
|
Pain Self-Efficacy Scale - 2 item
Time Frame: 3 months after inclusion
|
The Pain Self-Efficacy Questionnaire (PSEQ) is an established 10-item measure of pain self-efficacy that is widely used in clinical and research settings.
In the present study a short form of the original questionnaire will be used.
The two items are graded from 0 = not at all certain to 6 = very certain.
|
3 months after inclusion
|
Pain Self-Efficacy Scale - 2 item
Time Frame: 12 months after inclusion
|
The Pain Self-Efficacy Questionnaire (PSEQ) is an established 10-item measure of pain self-efficacy that is widely used in clinical and research settings.
In the present study a short form of the original questionnaire will be used.
The two items are graded from 0 = not at all certain to 6 = very certain.
|
12 months after inclusion
|
Pain Self-Efficacy Scale - 2 item
Time Frame: 36 months after inclusion
|
The Pain Self-Efficacy Questionnaire (PSEQ) is an established 10-item measure of pain self-efficacy that is widely used in clinical and research settings.
In the present study a short form of the original questionnaire will be used.
The two items are graded from 0 = not at all certain to 6 = very certain.
|
36 months after inclusion
|
Assessment of carbon dioxide (CO2) equivalent emissions in kg - travelling
Time Frame: Baseline
|
Travelling to/from health care visits based on travel data reported in a questionnaire
|
Baseline
|
Assessment of CO2 equivalent emissions in kg - electronical devices
Time Frame: 3 months after inclusion
|
Use of electronical devices in a lifecycle perspective based on user data from app
|
3 months after inclusion
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jan Kilhamn, PhD, Research, Education, Development & Innovation, Primary Health Care, Region Västra Götaland, Sweden
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Digitalization OA care
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
-
National Yang Ming UniversityFar Eastern Memorial HospitalCompletedMedial Knee OsteoarthritisTaiwan
-
Hanlim Pharm. Co., Ltd.CompletedKnee OsteoarthritisKorea, Republic of
Clinical Trials on Patient information
-
University Hospital FreiburgCompletedDepression | Acute Low Back PainGermany
-
Oxford University Hospitals NHS TrustLiverpool John Moores University; National Cancer Research NetworkWithdrawn
-
Uskudar State HospitalNot yet recruiting
-
Linkoeping UniversityOstergotland County Council, Sweden; Swedish Heart Lung FoundationUnknown
-
McMaster UniversityCanadian Cancer Society (CCS)Completed
-
McMaster UniversityCanadian Cancer Society (CCS)Completed
-
University of MelbourneCompletedKnee Osteoarthritis | Patient EmpowermentAustralia
-
Hélène CorriveauCompletedStress | Anxiety | Stroke, Acute | Knowledge, Attitudes, PracticeCanada
-
FloralisGroupe Hospitalier Mutualiste de GrenobleCompletedAnkle Sprain | Diverticulitis | Pyelonephritis | Prostatitis | Infectious Colitis | PneumonitisFrance
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Completed